PROTEIN SUBUNIT AND MRNA COVID-19 VACCINES: COMPARATIVE STUDY ON INDUCED-IMMUNOGENICITY IN RITUXIMAB-TREATED PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS, RHEUMATOID ARTHRITIS AND VASCULITIS

This article has no abstract
Epistemonikos ID: f65aff1c407fac7a0e3777ecffa7fea1f00e3556
First added on: Jul 12, 2025